Fig. 2: Adjusted odds ratio (left) and vaccine effectiveness (right) against SARS-CoV-2 breakthrough infection.
From: Waning effectiveness of the third dose of the BNT162b2 mRNA COVID-19 vaccine
Left: Data are presented as adjusted OR, as a function of time in months (calendrical month) since the administration of the third dose, with error bars indicating the corresponding 95% Wald’s C.I. Right: Data are presented as adjusted VE, as a function of time in months (calendrical month) since the administration of the third dose, with error bars indicating the corresponding 95% Wald’s C.I.
